What is it? Why is it important?

A contract is a written, dated, and signed document between two or more parties. The contract delineates delegated tasks, outlines corresponding responsibilities, and defines the financial aspects.

 

Partner contracts are establised with:

  • Outsourced service providers:
    • Hospital internal services (e.g. pathology, radiology, laboratories, pharmacy)
    • Hospital external services, such as vendors providing selected study services, materials, and expertise (e.g. laboratories, monitoring, statistics, data management, insurance companies)
  • Study sites of a multicentre study: are studies with more than one study site (i.e. irrespective of language region)

 

Contract development can include many players:

  • The SP-INV of the study
  • Hospital legal department
  • Hospital management
  • Partner representatives (e.g. additional study sites, laboratory, monitoring, data management, statistical services)
  • Partner legal department

What do I need to do?

As a SP-INV, consider the following aspects when drafting the contract:

  • Type of service requested
  • Nature of the collaboration
  • Respective tasks and responsibilities
  • Expected timeline of provided service, including milestones
  • Financial agreement, including a payment plan. Pay-outs can be planned in a step-like manner, such as after reaching a study milestone (e.g. upon Ethics Committe (EC) approval or after inclusion of a set number of participants).
  • The confidentiality agreeement
  • Publication rights
  • The handling of legal disputes

 

A contract is reviewed and approved by the:

  • Hospital legal department and its management
  • Partner and its legal department

 

Allow ample time for contract development. Given the involvement of multiple parties, approval may take a considerable amount of time.

 

Signed contracts between the SP-INV and the grant provider(s) or the Site-INV(s) in a multi-centre study must be submitted to the Ethics Committee (EC).

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

External Links

Swissethics – see in particular

  • Clinical study agreement template

References

ICH GCP E6(R2) – see in particular guidelines

  • 1.17 Contract definition
  • 4.5.1 Site contract
  • 4.9.6 Financial agreement
  • 5.9 Financing

 

ISO 14155:2020 Medical devices (access liable to cost) - see in particular sections

  • 6.9 Agreements
  • 9.3 Outsourcing
Abbreviations
  • CTU – Clinical Trials Unit
  • EC – Ethics Committee
  • EC - Ethics Committee
  • ICH-GCP – International Council for Harmonisation - Good Clinical Practice
  • ISO – International Organization for Standardization
  • Site-INV – Site Ivestigator
  • SP-INV – Sponsor-Investigator
Development ↦ Management ↦ Study Management ↦ Contract
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Development ↦ Management ↦ Study Management ↦ Contract

Please note: the Easy-GCS tool is currently under construction.